Project Grant K23AG088376

Award Date 9/3/24
Completion Date 6/30/29
Dollars Obligated $193K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $481,428 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Research Programs (CFDA 93.273) will support the "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team" project. The key products and services to be delivered under this 4-year project include: Two 16-session cohorts of Project ECHO (Extension for Community Healthcare Outcomes) Alcohol Use Disorder...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a $503,750 research study to examine the effects of chronic pain on alcohol consumption behavior in heavy drinkers with temporomandibular disorder (TMD) pain. The primary objective is to determine the impact of pain on drinking topography, or the microstructure of individual drinking bouts, both in a controlled laboratory setting and...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $468,534 to the University of Southern California to examine alcohol consumption as a modifiable risk factor for Alzheimer's disease and related dementias (ADRD). The study aims to delineate the relationship between midlife alcohol consumption and late-life ADRD diagnosis and onset, with a focus on potential sex differences. It will also test the interaction between alcohol consumption...
This federal Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), provides $150,497 to the Ann & Robert H. Lurie Children's Hospital of Chicago to adapt and implement the Screening, Brief Intervention, and Referral to Treatment (SBIRT) approach for adolescents with chronic medical conditions (A-CMC) who are hospitalized in pediatric inpatient units. The key objectives of this 5-year project are to: 1)...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will provide $119,600 over a 3-year period from July 2024 to July 2027 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to conduct research on the mechanisms by which aging and alcohol consumption cooperatively contribute to the development of alcohol-associated liver disease (ALD). The project aims to identify how...
This federal Project Grant award, totaling $517,248.00, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) grant program. The award supports research to explore the mechanisms by which acute and chronic alcohol exposure regulate a norepinephrine-astrocyte-dopamine arousal pathway in the ventral periaqueductal gray (VPAG) region of the brain, and how this pathway contributes to alcohol-related changes in sleep behavior....
This $366,406 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to Yale University. The grant will be used to develop two novel human laboratory models to screen potential medications for Alcohol Use Disorder (AUD). The first model will assess a medication's ability to increase abstinence and reduce heavy drinking, which align with key FDA endpoints for AUD medication approval. The second model will...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $194,551 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The Medical University of South Carolina. The funding supports research to investigate the effects of adolescent intermittent ethanol exposure on the regulation of a neural pathway involving the prelimbic cortex and ventrolateral periaqueductal gray, and its impact on pain processing and sensitivity. The research aims to elucidate how changes in the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $656,000.00 to The Regents of the University of California, San Francisco to conduct research on pain management in the elderly. The project aims to investigate whether "hyperalgesic priming" - a form of neuroplasticity that increases pain sensitivity - contributes to the high incidence of chronic pain in older adults. Key objectives include: Establishing whether aged rats exhibit...
This $5,262,301 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) is for the "Triangulation of Innovative Methods to END Alzheimer's Disease (TIME-AD)" program. The program aims to strengthen causal inference in observational data on modifiable risk factors for Alzheimer's disease and related dementias (AD/ADRD) using an evidence triangulation framework. The award funds four research projects that will employ a variety of innovative causal...

This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $192,851 provides funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop, refine, and pilot test an Alcohol Screening, Brief Intervention, and Referral to Treatment (A-SBIRT) protocol tailored for older adults with chronic pain. The goal is to create an affordable, scalable, and efficient intervention that can increase motivation and self-efficacy to reduce hazardous drinking, decrease hazardous alcohol use, and improve chronic pain and aging-related outcomes among this population. The award supports the initial stage of this research, including stakeholder input, a mixed methods pilot trial, and a feasibility pilot RCT, with the aim of informing a subsequent larger-scale efficacy trial.

Generated 7/1/25, 2:15 AM